What is the SonablateÂ®Â 500 and how does it treat prostate cancer?
The SonablateÂ®Â 500 ("Sonablate") is aÂ medical device designed to treat prostate cancer with HIFU energy. The Sonablate captures real-time images of the prostate gland, allowing the physician to create a customized treatment plan for each patient. The physician uses the Sonablate to deliver the ultrasound energy to targeted sites, or focal points, throughout the prostate gland.
Sonablate HIFU is a minimally invasive, outpatient treatment choice for prostate cancer that does not involve surgery or radiation. The Sonablate was developed by Focus Surgery Inc., located in Indianapolis, IN, and is the only HIFU device for prostate cancer that does not require a TURP procedure for prostates smaller than 40cc prior to treatment in order to achieve effective results.
The Sonablate uses a fully integrated probe with two transducers, one to image the prostate gland and the other to treat with HIFU.
HIFU with Tissue Change Monitoring (TCM)
Tissue Change Monitoring (TCM) is a unique quantitative software module exclusively designed for the Sonablate that monitors real-time tissue changes during Sonablate HIFU for the treatment of malignant and benign prostate disease. TCM provides feedback on the status of the ablative therapy in real time so the physician knows whether sufficient HIFU energy has been applied to the focal zone for treatment during Sonablate HIFU.